Form EFFECT Astria Therapeutics,
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | January 27, 2026 |
| Accession Number: | 0001140361-26-002207 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Legendary Fruit Company Enters Letter of Intent with Gebbers Farms
- EquipmentShare to Present at the Wells Fargo 16th Annual Industrials & Materials Conference
- As the Looming Crisis Takes Hold, Jet Fuel Inventories Hit a 63-Year Low and Europe Faces Imminent Supply Failure, Genoil Inc. Offers the Only Viable Solution That Can Close the Gap
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
